Status: Recruiting
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
Participants needed: 149
Trial details
Biological sex: AllType: ObservationalSponsor: Kissei Pharmaceutical Co., Ltd.Updated: Jan 3, 2025Locations: 1Duration: 18 Months
Eligibility criteria
Patients with chronic idiopathic thrombocytopenic purpura who are treatment with...